Fingerprint
Dive into the research topics of 'Phase II study of bevacizumab and temsirolimus combination therapy for recurrent glioblastoma multiforme'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of bevacizumab and temsirolimus combination therapy for recurrent glioblastoma multiforme
Ulrik Lassen, Morten Sorensen, Tine Bernhardtsen Gaziel, Benedikte Hasselbalch, Hans Skovgaard Poulsen
67
Citations
(Scopus)